Company Description

Biocerta is an ex vivo screen that uses a patient’s own tumor tissue to guide personalized treatment decisions. It gives oncologists clear data on which FDA-approved therapies show real activity against that patient’s tumor, helping them choose the options with the highest likelihood of success.